Alpha 2.0
Login Register
» Articles » PMID: 27863715

Kawasaki Disease and Immunisation: Standardised Case Definition & Guidelines for Data Collection, Analysis

Overview
Journal Vaccine
Specialty Allergy & Immunology
Date 2016 Nov 20
PMID 27863715
Citations 7
Authors
Linny Kimly Phuong
Caterina Bonetto
Jim Buttery
Yolanda Brauchli Pernus
Rebecca Chandler
Karen L Goldenthal
Merita Kucuku
Giuseppe Monaco
Barbara Pahud
Stanford T Shulman
Karina A Top
Rolando Ulloa-Gutierrez
Frederick Varricchio
Sarah de Ferranti
Jane W Newburger
Nagib Dahdah
Surjit Singh
Jan Bonhoeffer
David Burgner
Affiliations
Soon will be listed here.
Citing Articles

Kawasaki disease and the environment: an enigmatic interplay.

Aggarwal R, Pilania R, Sharma S, Kumar A, Dhaliwal M, Rawat A Front Immunol. 2024; 14:1259094.

PMID: 38164136 PMC: 10757963. DOI: 10.3389/fimmu.2023.1259094.

[Evidence-based guidelines for the diagnosis and treatment of Kawasaki disease in children in China (2023)].

Zhongguo Dang Dai Er Ke Za Zhi. 2023; 25(12):1198-1210.

PMID: 38112136 PMC: 10731970. DOI: 10.7499/j.issn.1008-8830.2309038.

Kawasaki disease following immunization reported to the Canadian Immunization Monitoring Program ACTive (IMPACT) from 2013 to 2018.

Alsager K, Vadlamudi N, Jadavji T, Bettinger J, Constantinescu C, Vaudry W Hum Vaccin Immunother. 2022; 18(5):2088215.

PMID: 35797728 PMC: 9621042. DOI: 10.1080/21645515.2022.2088215.

Developing standard safety outcomes for COVID-19 vaccines.

Buttery J Vaccine. 2021; 39(22):3025-3027.

PMID: 33888324 PMC: 7953438. DOI: 10.1016/j.vaccine.2021.03.004.

Kawasaki Disease following administration of 13-valent pneumococcal conjugate vaccine in young children.

Yung C, Ma X, Cheung Y, Oh B, Soh S, Thoon K Sci Rep. 2019; 9(1):14705.

PMID: 31604998 PMC: 6788987. DOI: 10.1038/s41598-019-51137-5.